Mouse peritoneal macrophages contain abundant ω-6 lipoxygenase activity that is independent of interleukin-4

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 12, 1996, Pages 1488-1494

  Cornicelli, Joseph A ^a   Welch, Kathryn ^a   Auerbach, Bruce ^a   Feinmark, Steven J ^b   Daugherty, Alan ^c  

^a PFIZER INC   (United States)

^b Columbia University ^*  (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

interleukin 4; lipoxygenase; macrophage; regulation

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; INTERLEUKIN 4; LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; LIPID PEROXIDATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0030479247     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.12.1488     Document Type: Article

References (47)

1. Samuelsson B, Dahlen S-E, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987;237:1171-1176.
2. Kuhn H, Brash AR. Occurrence of lipoxygenase products in membranes of rabbit reticulocytes: evidence for a role of the reticulocyte lipoxygenase in the maturation of red cells. J Biol Chem. 1990; 265:1454-1458.
3. Sparrow CP, Parthasarathy S, Steinberg D. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J Lipid Res. 1988;29:745-753.
4. Cathcart MK, McNally AK, Chisolm GM. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J Lipid Res. 1991;32:63-70.
5. Schewe T, Rapoport SM, Kuhn H. Enzymology and physiology of reticulocyte lipoxygenase: comparison with other lipoxygenases. Adv Enzymol Relat Areas Mol Biol. 1986;58:192-271.
6. Rapoport SM, Schewe T, Wiesner R, Halangk W, Ludwig P, Janicke-Hohne M, Tannert C, Hiebsch C, Klatt D. The lipoxygenase of reticulocytes: purification, characterization, and biological dynamics of the lipoxygenase: its identity with the respiratory inhibitors of the reticulocyte. Eur J Biochem. 1979;96:545-561.
7. Schewe T, Wiesner R, Rapoport SM. Lipoxygenase from rabbit reticulocytes. Methods Enzymol. 1981;71:430-441.
8. Nadel JA, Conrad DJ, Ueki IF, Schuster A, Sigal E. Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes, and airway cells. J Clin Invest. 1991;87:1139-1145.
9. Sigal E, Dicharry S, Highland E, Finkbeiner WE. Cloning of human airway 15-lipoxygenase: identity to the reticulocyte enzyme and expression in epithelium. Am J Physiol Lung Cell Mol Physiol. 1992;262:L392-L398.
10. Shannon VR, Chanez P, Bousquet J, Holtzman MJ. Histochemical evidence for induction of arachidonate 15-lipoxygenase in airway disease. Am Rev Respir Dis. 1993;147:1024-1028.
11. Hunter JA, Finkbeiner WE, Nadel JA, Goetzl EJ, Holtzman MJ. Pre-dominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci U S A. 1985:82:4633-4637.
12. Shannon VR, Crouch EC, Takahashi Y, Ueda N, Yamamoto S, Holtzman MJ. Related expression of arachidonate 12- and 15-lipoxygenases in animal and human lung tissue. Am J Physiol Lung Cell Mol Physiol. 1991;261:L399-L405.
13. Shannon VR, Ramanadham S, Turk J, Holtzman MJ. Selective expression of an arachidonate 12-lipoxygenase by pancreatic islet β-cells. Am J Physiol Endocrinol Metab. 1992;263:E828-E836.
14. Shannon VR, Stenson WF, Holtzman MJ. Induction of epithelial arachidonate 12-lipoxygenase at active sites of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 1993;264: G104-G111.
15. Conrad DJ, Kuhn H, Mulkins M, Highland E, Sigal E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci U S A. 1992;89:217-221.
16. Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Sarkioja T, Witztum JL, Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid protein adducts. J Clin Invest. 1991;87:1146-1152.
17. Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, Glass CK, Sigal E, Witztum JL, Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A. 1990;87:6959-6963.
18. Daugherty A, Roselaar SE. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. Cardiovasc Res. 1995;29:297-311.
19. Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta. 1992;1128:117-131.
20. Chen XS, Kurre U, Jenkins NA, Copeland NG, Funk CD. cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases. J Biol Chem. 1994;269:13979-13987.
21. Sloane DL, Leung R, Craik CS, Sigal E. A primary determinant for lipoxygenase positional specificity. Nature. 1991;354:149-152.
22. Sigal E, Sloane DL, Conrad DJ. Human 15-lipoxygenase: induction by interleukin-4 and insights into positional specificity. J Lipid Mediat. 1993;6:75-88.
23. Gan Q-F, Witkop GL, Sloane DL, Straub KM, Sigal E. Identification of a specific methionine in mammalian 15-lipoxygenase that is oxygenated by the enzyme product 13-HPODE: dissociation of sulfoxide formation from self-inactivation. Biochemistry. 1995; 34:7069-7079.
24. Sloane DL, Leung R, Barnett J, Craik CS, Sigal E. Conversion of human 15-lipoxygenase to an efficient 12-lipoxygenase: the side-chain geometry of amino acids 417 and 418 determine positional specificity. Protein Eng. 1995;8:275-282.
25. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Köhler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 1993;362:245-248.
26. Nakagawara A, Nathan CF. A simple method for counting adherent cells: application to cultured human monocytes, macrophages, and multinucleated giant cells. J Immunol. 1983;56:261-268.
27. Auerbach BJ, Kiely JS, Cornicelli JA. A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Anal Biochem. 1992;201:375-380.
28. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4355.
29. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST. Interleukin 4 is localized to and released by human mast cells. J Exp Med. 1992;176:1381-1386.
30. Banchereau J, Brière F, Galizzi JP, Miossec P, Rousset F. Human interleukin 4. J Lipid Mediat. 1994;9:43-53.
31. Paul WE, Ohara J. B-cell stimulatory factor/interleukin 4. Annu Rev Immunol. 1987;5:429-459.
32. Kühn R, Rajewsky K, Müller W. Generation and analysis of interleukin-4 deficient mice. Science. 1991;254:707-710.
33. Doherty TM, Kastelein R, Menon S, Andrade S, Coffman RL. Modulation of murine macrophage function by IL-13. J Immunol. 1993;151:7151-7160.
34. Moore KW, O'Garra A, De Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol. 1993;11:165-190.
35. Nassar GM, Morrow JD, Roberts LJ II, Lakkis FG, Badr KF. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J Biol Chem. 1994;269:27631-27634.
36. Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen J, Serhan CN. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,1 1-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest. 1993;92:1572-1579.
37. Yla-Herttuala S. Gene expression in atherosclerotic lesions. Herz. 1992;17:270-276.
38. Stemme S, Holm J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb. 1992;12:206-211.
39. Stemme S, Rymo L, Hansson GK. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest. 1991;65:654-660.
40. Hansson GK, Seifert PS, Olsson G, Bondjers G. Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. Arteriosclerosis. 1991;11:745-750.
41. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138.
42. Stemme S, Hansson GK. Immune mechanisms in atherosclerosis. Coron Artery Dis. 1994;5:216-222.
43. Swanson SJ, Rosenzweig A, Seidman JG, Libby P. Diversity of T-cell antigen receptor Vbeta gene utilization in advanced human atheroma. Arterioscler Thromb. 1994;14:1210-1214.
44. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
45. Kuhn H, Belkner J, Wiesner R, Brash AR. Oxygenation of biological membranes by the pure reticulocyte lipoxygenase. J Biol Chem. 1990;265:18351-18361.
46. Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest. 1994;94:877-884.
47. Rao GN, Alexander RW, Runge MS. Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-fos, c-jun, and c-myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells. J Clin Invest. 1995;96:842-847.